OBJECTIVE: Physiotherapies are the most widely recommended conservative treatment for arthritic diseases. The present study was undertaken to examine the molecular mechanisms underlying the effects of gentle treadmill walking (GTW) on various stages of monoiodoacetate-induced arthritis (MIA) to elucidate the basis for the success or failure of such therapies in joint damage. METHODS: Knees were obtained from untreated control rats, rats with MIA that did not undergo GTW, rats with MIA in which GTW regimens were started 1 day post-MIA induction, and rats with MIA in which GTW regimens were started after cartilage damage had progressed to grade 1 or grade 2. The cartilage was examined macroscopically, microscopically, and by microfocal computed tomography imaging. Transcriptome-wide gene expression analysis was performed, and microarray data were assessed by Ingenuity Pathways Analysis to identify molecular functional networks regulated by GTW. RESULTS: GTW intervention started on day 1 post-MIA induction significantly prevented the progression of MIA, but its efficacy was reduced when implemented on knees exhibiting close to grade 1 cartilage damage. GTW accelerated cartilage damage in knees with close to grade 2 damage. Transcriptome-wide gene expression analysis revealed that GTW intervention started 1 day post-MIA inception significantly suppressed inflammation-associated genes and up-regulated matrix-associated gene networks. However, delayed GTW intervention after grade 1 damage had occurred was less effective in suppressing proinflammatory genes or up-regulating matrix synthesis. CONCLUSION: The present findings suggest that GTW suppresses proinflammatory gene networks and up-regulates matrix synthesis to prevent progression of cartilage damage in MIA-affected knees. However, the extent of cartilage damage at the initiation of GTW may be an important determinant of the success or failure of such therapies.
OBJECTIVE: Physiotherapies are the most widely recommended conservative treatment for arthritic diseases. The present study was undertaken to examine the molecular mechanisms underlying the effects of gentle treadmill walking (GTW) on various stages of monoiodoacetate-induced arthritis (MIA) to elucidate the basis for the success or failure of such therapies in joint damage. METHODS: Knees were obtained from untreated control rats, rats with MIA that did not undergo GTW, rats with MIA in which GTW regimens were started 1 day post-MIA induction, and rats with MIA in which GTW regimens were started after cartilage damage had progressed to grade 1 or grade 2. The cartilage was examined macroscopically, microscopically, and by microfocal computed tomography imaging. Transcriptome-wide gene expression analysis was performed, and microarray data were assessed by Ingenuity Pathways Analysis to identify molecular functional networks regulated by GTW. RESULTS:GTW intervention started on day 1 post-MIA induction significantly prevented the progression of MIA, but its efficacy was reduced when implemented on knees exhibiting close to grade 1 cartilage damage. GTW accelerated cartilage damage in knees with close to grade 2 damage. Transcriptome-wide gene expression analysis revealed that GTW intervention started 1 day post-MIA inception significantly suppressed inflammation-associated genes and up-regulated matrix-associated gene networks. However, delayed GTW intervention after grade 1 damage had occurred was less effective in suppressing proinflammatory genes or up-regulating matrix synthesis. CONCLUSION: The present findings suggest that GTW suppresses proinflammatory gene networks and up-regulates matrix synthesis to prevent progression of cartilage damage in MIA-affected knees. However, the extent of cartilage damage at the initiation of GTW may be an important determinant of the success or failure of such therapies.
Authors: K P H Pritzker; S Gay; S A Jimenez; K Ostergaard; J-P Pelletier; P A Revell; D Salter; W B van den Berg Journal: Osteoarthritis Cartilage Date: 2005-10-19 Impact factor: 6.576
Authors: E Ortega; J J García; M E Bote; L Martín-Cordero; Y Escalante; J M Saavedra; H Northoff; E Giraldo Journal: Exerc Immunol Rev Date: 2009 Impact factor: 6.308
Authors: M Geyer; S Grässel; R H Straub; G Schett; R Dinser; J Grifka; S Gay; E Neumann; U Müller-Ladner Journal: Osteoarthritis Cartilage Date: 2008-09-04 Impact factor: 6.576
Authors: Ida C Helmark; Ulla R Mikkelsen; Jens Børglum; Anders Rothe; Marie C H Petersen; Ove Andersen; Henning Langberg; Michael Kjaer Journal: Arthritis Res Ther Date: 2010-07-01 Impact factor: 5.156
Authors: Karupppasamy Subburaj; Deepak Kumar; Richard B Souza; Hamza Alizai; Xiaojuan Li; Thomas M Link; Sharmila Majumdar Journal: Am J Sports Med Date: 2012-06-22 Impact factor: 6.202
Authors: J P Halloran; S Sibole; C C van Donkelaar; M C van Turnhout; C W J Oomens; J A Weiss; F Guilak; A Erdemir Journal: Ann Biomed Eng Date: 2012-05-31 Impact factor: 3.934
Authors: J Nam; P Perera; R Gordon; Y H Jeong; A D Blazek; D G Kim; B C Tee; Z Sun; T D Eubank; Y Zhao; B Lablebecioglu; S Liu; A Litsky; N L Weisleder; B S Lee; T Butterfield; A L Schneyer; S Agarwal Journal: Bone Date: 2015-04-30 Impact factor: 4.398
Authors: A D Blazek; J Nam; R Gupta; M Pradhan; P Perera; N L Weisleder; T E Hewett; A M Chaudhari; B S Lee; B Leblebicioglu; T A Butterfield; S Agarwal Journal: Osteoarthritis Cartilage Date: 2016-02-27 Impact factor: 6.576
Authors: Lindsey K Lepley; Patrick O McKeon; Shane G Fitzpatrick; Catherine L Beckemeyer; Timothy L Uhl; Timothy A Butterfield Journal: J Athl Train Date: 2016-11-10 Impact factor: 2.860
Authors: Derrick M Knapik; Joshua D Harris; Garett Pangrazzi; Michael J Griesser; Robert A Siston; Sudha Agarwal; David C Flanigan Journal: Arthroscopy Date: 2013-07-26 Impact factor: 4.772
Authors: Derrick M Knapik; Priyangi Perera; Jin Nam; Alisa D Blazek; Björn Rath; Binnaz Leblebicioglu; Hiranmoy Das; Lai Chu Wu; Timothy E Hewett; Suresh K Agarwal; Alexander G Robling; David C Flanigan; Beth S Lee; Sudha Agarwal Journal: Antioxid Redox Signal Date: 2013-08-12 Impact factor: 8.401